Adventure, Inc. Logo

Adventure, Inc.

A Japanese OTA providing competitive rates for global travel bookings in over 30 languages.

6030 | T

Overview

Corporate Details

ISIN(s):
JP3122380003
LEI:
Country:
Japan
Address:
渋谷区恵比寿4−20−3恵比寿ガーデンプレイスタワー24F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Adventure, Inc. is a Japanese online travel agency (OTA) that operates the comprehensive travel booking platform, skyticket. The platform provides a wide array of services in over 30 languages, including reservations for flights, hotels, rental cars, package tours, ferries, and WiFi rentals. A pioneer in online bookings for low-cost carriers (LCCs), the company focuses on offering competitive rates and a seamless user experience. Founded in 2006 with the philosophy of a social business, Adventure, Inc. aims to contribute to society by stimulating local economies and creating employment opportunities through the global tourism industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 07:52
Registration Form
確認書
Japanese 8.9 KB
2025-10-31 07:50
Registration Form
有価証券報告書-第19期(2024/07/01-2025/06/30)
Japanese 1.1 MB
2025-06-25 02:59
Major Shareholding Notification
変更報告書
Japanese 40.3 KB
2025-02-13 07:32
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-02-13 07:31
Interim Report
半期報告書-第19期(2024/07/01-2025/06/30)
Japanese 295.3 KB
2024-12-06 04:01
Major Shareholding Notification
変更報告書
Japanese 44.5 KB
2024-11-13 04:13
Major Shareholding Notification
大量保有報告書
Japanese 42.2 KB
2024-10-01 08:05
Regulatory News Service
臨時報告書
Japanese 25.8 KB
2024-09-27 08:22
Governance Information
内部統制報告書-第18期(2023/07/01-2024/06/30)
Japanese 23.6 KB
2024-09-27 08:20
Registration Form
確認書
Japanese 8.9 KB
2024-09-27 08:19
Annual Report
有価証券報告書-第18期(2023/07/01-2024/06/30)
Japanese 1.1 MB
2024-09-13 08:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.1 KB
2024-08-15 08:22
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.2 KB
2024-05-21 08:54
Regulatory News Service
臨時報告書
Japanese 20.5 KB
2024-05-13 08:09
Report Publication Announcement
確認書
Japanese 8.8 KB

Automate Your Workflow. Get a real-time feed of all Adventure, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adventure, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Adventure, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.